SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Credit Acceptance amended its existing revolving credit facility, extending the maturity by one year to June 22, 2029, and reducing the interest rate by 22.5 basis points on the $270.5 million outstanding balance. This refinancing improves the company's borrowing terms and liquidity position.
View raw filing on EDGAR →The company issued a press release on June 9, 2026 regarding a material transaction, but the specific nature of the transaction is not detailed in the Item 8.01 excerpt provided and would require review of the attached exhibit.
View raw filing on EDGAR →Oklahoma Gas & Electric Co entered into a material definitive agreement and amended and restated two $650 million unsecured revolving credit facilities (one for OGE Energy and one for OG&E), replacing prior $550 million facilities. The new facilities are undrawn as of closing and contain customary financial covenants.
View raw filing on EDGAR →Dauch announced ratification of a new four-year collective bargaining agreement with UAW Local 2093 at its Three Rivers Manufacturing Facility. While labor agreements can materially affect operating costs and labor relations, this disclosure does not fit neatly into the specific event categories (it is neither a departure, appointment, compensation arrangement, M&A activity, nor litigation). The materiality stems from the multi-year commitment and potential cost implications of the agreement, making it a material event that warrants classification as "other_material."
View raw filing on EDGAR →The filing discloses completion of production tooling for SpinDetect™, commissioning of a cleanroom facility, and a staged commercial rollout plan. While these are operational milestones that could be material to investors assessing the company's product development progress and commercialization readiness, the disclosure does not fit neatly into the standard event taxonomy (not earnings, M&A, executive changes, impairment, litigation, or cybersecurity). This is best classified as other_material given the strategic significance of manufacturing readiness and commercial launch planning.
View raw filing on EDGAR →Item 2.03 discloses creation of a direct financial obligation or off-balance sheet arrangement, with substance incorporated by reference from Item 1.01; the specific nature of the obligation cannot be determined without access to the full Item 1.01 content.
View raw filing on EDGAR →Comtech created a direct financial obligation, the specific nature of which is incorporated by reference from Item 1.01 and may include debt incurred in connection with the transaction, contingent consideration, or other financing arrangements.
View raw filing on EDGAR →Comtech disclosed a material modification to the rights of security holders, the specific nature of which is incorporated by reference from Item 1.01 and may involve charter amendments, recapitalizations, or similar structural changes.
View raw filing on EDGAR →Ironwood repaid $200 million in aggregate principal of convertible senior notes at scheduled maturity using available cash on hand. While this is a routine debt maturity event, the materiality of the amount ($200M) and the use of cash reserves to fund repayment would affect a reasonable investor's assessment of the company's liquidity and capital allocation. The disclosure does not fit neatly into debt covenant breach (no violation occurred) or other more specific categories, making "other_material" the most appropriate classification.
View raw filing on EDGAR →Jackson Financial issued $750 million of 6.150% Senior Notes due 2037 on June 15, 2026, creating a direct financial obligation under Item 2.03. While this is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, it does not fit cleanly into the more specific event categories (e.g., it is not a covenant breach, going concern issue, or M&A activity). The disclosure focuses on the mechanics of the debt offering rather than signaling financial distress or a transformative corporate event.
View raw filing on EDGAR →Shareholders approved amendments to the Company's Articles of Association, including adoption of the Dutch large company regime, an increase in authorized share capital, and establishment of an exclusive federal forum for certain disputes. These structural and governance changes affect the company's legal framework and shareholder rights.
View raw filing on EDGAR →Simon Property Group completed a €500 million debt offering of 3.650% guaranteed notes due 2031 on June 15, 2026, with the Operating Partnership providing a full guarantee. While this is a material financing event affecting the registrant's capital structure and financial obligations, it does not fit cleanly into the standard taxonomy categories (not an earnings release, M&A activity, impairment, covenant breach, or other specifically enumerated event types). The disclosure describes a completed debt issuance with customary terms and covenants, which is material to investors but lacks the distress signals of covenant_breach or going_concern.
View raw filing on EDGAR →The Board approved a $60 million increase to the stock repurchase program, raising total authorized capacity to $100 million. While share repurchase authorizations are common corporate actions, this material increase in buyback capacity signals management's confidence in the company's financial position and capital allocation strategy, which would affect a reasonable investor's assessment of capital deployment and shareholder returns. However, the disclosure lacks the specificity of earnings, M&A, or executive changes, placing it in the "other_material" category rather than a more specific event type.
View raw filing on EDGAR →Viatris entered into an underwriting agreement to issue €650 million in Senior Notes due 2033 at 4.250%, with closing expected June 17, 2026. This is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, but does not fit the more specific taxonomy categories (not a dilutive equity issuance, not M&A, not a restatement or covenant breach). The disclosure is appropriately classified as other_material rather than dilutive_issuance, which applies to equity securities.
View raw filing on EDGAR →The disclosure describes a reverse stock split (1-for-6 ratio) approved by stockholders and implemented via amendment to the Certificate of Incorporation, effective June 11, 2026. While this is a structural capital event affecting all shareholders proportionately, it does not fit neatly into the standard taxonomy categories. The event is material because it affects share count, trading mechanics, and investor holdings, but it is primarily a routine corporate action rather than a sign of financial distress or operational change. Classified as "other_material" because reverse splits, though significant, are administrative capital structure adjustments distinct from the more acute events (impairment, covenant breach, delisting risk) that typically signal material financial or operational trouble.
View raw filing on EDGAR →Safety Insurance entered Amendment No. 7 to its revolving credit facility, doubling the committed amount from $50 million to $100 million and extending the maturity date to June 9, 2031, materially expanding the company's liquidity and extending its debt maturity profile.
View raw filing on EDGAR →Nutrien has disclosed an unsolicited mini-tender offer by Ocehan LLC targeting approximately 0.02% of outstanding shares at a 24.91%–26.13% discount to market price. While mini-tender offers are typically small and routine, this disclosure is material because it alerts shareholders to a below-market offer and warns of potential investor confusion—a concern flagged by both the CSA and SEC. The company's explicit caution and recommendation against the offer, combined with the regulatory context, makes this a material shareholder communication that would affect investor decision-making, even though the offer itself is small and unsolicited.
View raw filing on EDGAR →Woodside issued a formal announcement denying media speculation about a potential transaction with Exxon Mobil Corporation, explicitly stating it is "not aware of any proposal and confirms it is not in discussions" regarding such a transaction. While this is a denial rather than disclosure of an actual M&A event, the announcement addresses material market speculation about a potential change of control or major acquisition that would significantly affect investor assessment. The company's need to issue a formal denial through its Disclosure Committee indicates the speculation was sufficiently material to warrant official clarification, though the event itself (a denial of rumors) does not fit neatly into the M&A activity category since no actual transaction is being disclosed.
View raw filing on EDGAR →Lexeo Therapeutics announced material regulatory updates regarding LX2006 for Friedreich ataxia cardiomyopathy, including pivotal study design to support accelerated approval pathway. This represents significant clinical and regulatory progress for the company's gene therapy candidate.
View raw filing on EDGAR →Alkermes announced the grant of orphan drug designations by the FDA and European Commission for alixorexton in idiopathic hypersomnia and narcolepsy indications, providing significant regulatory and commercial benefits including extended market exclusivity, tax credits, and reduced approval timelines.
View raw filing on EDGAR →Seadrill announced a $600 million senior unsecured notes offering by its subsidiary Seadrill Finance, intended for eligible purchasers under Rule 144A and Regulation S. While this is a material financing activity that would affect investor assessment of the company's capital structure and liquidity, it does not fit cleanly into the M&A taxonomy (which focuses on acquisitions, dispositions, mergers, or changes of control). The disclosure is a debt issuance announcement rather than an equity dilution or traditional M&A event, warranting classification as other_material.
View raw filing on EDGAR →The company announced failure of Phase 3 clinical trials (KOASTAL-2 and -3) for navacaprant in major depressive disorder, leading to discontinuation of the program. This represents a material setback to the company's pipeline and development strategy.
View raw filing on EDGAR →The company implemented a 35% reduction in force with $2 million in one-time restructuring costs and $10 million in annualized savings, triggered by discontinuation of navacaprant development. The restructuring reflects a material operational adjustment to the company's cost structure and workforce.
View raw filing on EDGAR →The company amended its Certificate of Incorporation to change its name from Sensei Biotherapeutics, Inc. to Faeth Therapeutics, Inc., with an associated ticker symbol change from SNSE to FTH, effective June 15, 2026. The name and symbol change was announced via press release and is material to investors as it affects company identification and trading.
View raw filing on EDGAR →Intellia Therapeutics announced positive Phase 3 clinical trial results for lonvo-z (NTLA-2002) in hereditary angioedema, demonstrating achievement of primary and key secondary endpoints with 87% reduction in attacks (p<0.0001) and favorable safety data, supporting advancement toward anticipated 2027 U.S. launch and BLA submission.
View raw filing on EDGAR →Strategy Inc amended the Certificate of Designations for its Variable Rate Series A Perpetual Stretch Preferred Stock (STRC), increasing dividend payment frequency from monthly to twice-monthly, and declared a conditional cash dividend on STRC at 11.50% per annum contingent upon effectiveness of the amended certificate.
View raw filing on EDGAR →The company announced a board-approved workforce reduction of approximately 50% with estimated restructuring costs of $5.7–$6.4 million in cash charges and $4.7–$5.0 million in non-cash stock-based compensation, plus $1.7 million in performance-based retention bonuses, designed to preserve cash while maintaining key strategic milestones.
View raw filing on EDGAR →The Board authorized a new 15,000,000-share repurchase program on June 15, 2026, replacing the prior 2024 program. While share repurchase authorizations are routine capital allocation decisions, this disclosure is material to investors as it signals management's confidence in valuation and affects future earnings per share and capital deployment strategy. However, it does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or covenant breach), making "other_material" the most appropriate classification.
View raw filing on EDGAR →This disclosure reports the Company's monthly Net Asset Value (NAV) per share as of May 31, 2026, calculated in accordance with board-approved valuation guidelines. The filing provides detailed breakdowns of NAV components (commercial mortgage loans, real estate owned, liabilities, etc.) and NAV per share across six share classes. While NAV disclosures are routine for non-traded REITs and investment companies, this particular filing is material to investors as it directly affects share valuation, redemption pricing, and investor assessment of the Company's asset base and financial position. The disclosure does not fit neatly into more specific event categories (not earnings, not M&A, not impairment, etc.), making "other_material" the most appropriate classification.
View raw filing on EDGAR →The filing discloses drilling and exploration results at the Shiloh Project via press release under Item 8.01 (Other Events). For a rare earths exploration company, material drilling results and project updates are typically significant to investors assessing resource potential and development progress. However, without access to the actual press release content (Exhibit 99.1), the specific materiality cannot be definitively assessed—the event could range from routine operational updates to discovery-level results. Classified as other_material given the exploration-stage context and lack of a more specific taxonomy match.
View raw filing on EDGAR →The filing discloses a Board decision to pursue dissolution and complete liquidation of ARI, requiring stockholder approval and filing of a preliminary proxy statement. While this is a transformative event materially affecting the company's future, it does not fit neatly into the specific taxonomy categories (not a bankruptcy filing, since it is a planned orderly liquidation; not M&A activity, since no specific transaction is announced; not going_concern, which typically addresses doubt about continuation). The dividend announcement is secondary to the dissolution disclosure.
View raw filing on EDGAR →The disclosure updates investors on the Company's carried interest position in special purpose vehicles holding shares of Space Exploration Technologies Corp. This represents a material update to shareholders regarding a significant asset holding (carried interest in SpaceX), which would affect a reasonable investor's assessment of the registrant's portfolio and financial position. However, without seeing the full press release content, the precise nature of the update (valuation change, structural modification, or other development) cannot be definitively categorized into a more specific event type, warranting classification as other_material.
View raw filing on EDGAR →The Company withdrew its Form F-1 registration statement (File No. 333-295510) effective June 15, 2026, and determined not to pursue the related public offering. This is a material capital-raising event that failed to proceed — the withdrawal of a pending IPO registration statement would affect a reasonable investor's assessment of the registrant's financing plans and strategic direction. While not a standard 8-K category, this is clearly a material financial/strategic event that does not fit neatly into the taxonomy (not a debt issuance, dilutive issuance, or M&A activity, but rather a failed equity offering).
View raw filing on EDGAR →The filing discloses an extension of the initial business combination deadline for a SPAC (blank-check company) from June 17, 2026 to July 16, 2026, contingent on the sponsor depositing $10,000 into the trust account. While this is a routine SPAC administrative action, the extension of the termination date is material to shareholders as it directly affects the timeline for completing the business combination and the potential return of capital if no combination is consummated. This does not fit neatly into the more specific event categories but is clearly material to investors in a SPAC.
View raw filing on EDGAR →Churchill Capital Corp XII announced the commencement of separate trading of Class A Ordinary Shares and Warrants from their Units, effective June 17, 2026. This is a material corporate action affecting the trading structure and liquidity of the company's securities, but does not fit neatly into the more specific event categories (it is not M&A, an executive change, a restatement, or other defined event types). The disclosure affects how investors can trade the underlying securities and is therefore material to the total mix of information available.
View raw filing on EDGAR →The Board approved Amendment No. 3 to the Tax Benefits Preservation Plan, extending its expiration date from July 1, 2026 to July 1, 2029. This technical amendment to the anti-dilution/tax-protection mechanism will require stockholder approval at the 2027 Annual Meeting.
View raw filing on EDGAR →SandRidge Energy entered into a material definitive agreement; the specific substance is incorporated by reference from Item 3.03 and involves modifications to the company's financial or security holder arrangements.
View raw filing on EDGAR →The disclosure announces advanced negotiations toward a master services agreement expected to provide 20 megawatts of power at the Michigan data center, valued in excess of $1.0 billion over 20 years. While this represents a material commercial opportunity that would affect investor assessment of the company's prospects, it does not fit cleanly into the M&A taxonomy (no acquisition, merger, or change of control) and is disclosed under Item 7.01 (Regulation FD) rather than Item 1.01 (M&A activity). The event is material but the specific nature—a major customer contract in advanced negotiation stage—is best classified as other_material.
View raw filing on EDGAR →The Mosaic Company entered into a $1 billion committed delayed draw term loan credit facility on June 10, 2026, with proceeds designated for debt refinancing. While this represents a material financing arrangement that would affect investor assessment of the company's liquidity and capital structure, it does not fit cleanly into the more specific event categories (it is not a dilutive equity issuance, covenant breach, or going-concern disclosure). The Item 7.01 Regulation FD Disclosure classification and the furnishing-only status suggest this is supplemental disclosure rather than a core material event triggering a specific Item.
View raw filing on EDGAR →The filing discloses two distinct corporate actions: (1) authorization of a stock repurchase plan for up to 1 million shares (~$25 million, 6% of outstanding shares) through June 2028, and (2) partial redemption of $40 million of subordinated debt notes on July 1, 2026. While the repurchase plan is routine capital allocation, the debt redemption is a material financing event affecting the company's capital structure and interest rate exposure. Neither event fits cleanly into the specific taxonomy categories (not M&A, not impairment, not covenant breach), making "other_material" the most appropriate classification for this mixed disclosure of capital management activities.
View raw filing on EDGAR →The filing discloses creation of a direct financial obligation under Item 2.03: FIF Utah received final funding approval for a $11.5M loan and $11.5M grant from USDA's Rural Utilities Service ReConnect Program. Boston Omaha Corporation unconditionally guaranteed the loan, creating a direct contingent liability. While this is a material financing event, it does not fit cleanly into the more specific categories (not a covenant breach, not a dilutive issuance, not M&A activity). The event is material as it represents a significant new debt obligation and guarantee affecting the company's financial position.
View raw filing on EDGAR →The Board authorized cash dividend declarations on common shares and preferred shares (Series E, F, G, and H) for the quarter. While dividend declarations are routine for REITs, this disclosure is material to investors assessing the company's capital allocation and financial health.
View raw filing on EDGAR →Elite Pharmaceuticals disclosed positive results from a pivotal bioequivalence study for a generic anticonvulsant product, demonstrating bioequivalence to the branded product and indicating the company's intent to file an Abbreviated New Drug Application (ANDA) with the FDA. While this represents material progress toward a regulatory milestone that could affect future revenue and competitive position, it does not fit neatly into the standard taxonomy categories (not an earnings release, M&A activity, impairment, or other defined event types). The disclosure is material to investors as it signals advancement in the company's pipeline and regulatory pathway.
View raw filing on EDGAR →The filing discloses receipt of a notice of allowance from the European Patent Office for a patent application titled "Systems and Methods for Dry Powder Coating Layers of an Electrochemical Cell," which covers key elements of the Company's proprietary dry electrode manufacturing platform. This is a material intellectual property development for a battery/energy technology company, but does not fit neatly into the standard event taxonomy (not earnings, M&A, executive changes, impairment, litigation, or cybersecurity). Patent allowances can be material to investors assessing competitive positioning and technology moat, particularly for an emerging growth company in the energy storage sector.
View raw filing on EDGAR →The filing discloses termination of an At-The-Market (ATM) offering agreement with H.C. Wainwright & Co., LLC, dated January 7, 2026. While this represents a material change to the Company's capital-raising capacity and financing flexibility, it does not fit cleanly into the dilutive_issuance category (which covers the initiation of such offerings) nor any other specific event type. The termination of an active ATM facility would materially affect investor assessment of the registrant's liquidity and financing options.
View raw filing on EDGAR →The filing discloses a peer-reviewed publication of preclinical data for Telomir-Zn in a diabetes model, announced via press release on June 15, 2026. While this represents positive scientific validation for the company's lead clinical program (which has IND clearance), it does not fit cleanly into the standard 8-K event taxonomy. The disclosure is material to investors as it provides evidence supporting the mechanism of action and scientific foundation of the company's pipeline, but it is neither an earnings release, executive change, M&A activity, nor any other specifically enumerated event type.
View raw filing on EDGAR →The filing discloses an "expanded relationship with VAST Data to power AI factories across Australia and Asia-Pacific" via press release under Item 7.01 (Regulation FD Disclosure). While the specific details are not provided in the 8-K body itself, the announcement of a material business partnership or strategic relationship with a named third party (VAST Data) for geographic expansion appears to be a significant corporate development. However, without access to the full press release text (Exhibit 99.1), the precise nature and materiality of this relationship—whether it constitutes a material contract, joint venture, or other arrangement—cannot be definitively determined, warranting classification as "other_material" rather than a more specific category.
View raw filing on EDGAR →The filing discloses a third drawdown of $30,000 under a sponsor promissory note on June 10, 2026, extending the Business Combination deadline from June 17 to July 17, 2026. This represents a material direct financial obligation and extension of a critical deadline for a SPAC, but does not fit cleanly into the standard taxonomy categories (not a covenant breach, as the note is unsecured and matures upon liquidation or closing; not a dilutive issuance, as it is a loan). The extension of the Termination Date is material to investors assessing the Company's timeline to complete its business combination.
View raw filing on EDGAR →The filing discloses a loan modification agreement extending the maturity date of a $8.5 million secured real estate loan from July 2, 2026 to July 2, 2027, with a $2.4 million payment ($1.5M principal paydown plus $0.9M in prepaid interest and fees). While this involves debt restructuring, it does not fit cleanly into covenant_breach (no violation alleged), ma_activity (no acquisition/disposition), or other specific categories. The extension of a material debt obligation's maturity date is material to investors assessing liquidity and financial obligations, warranting disclosure under Item 8.01 Other Events.
View raw filing on EDGAR →The filing discloses a press release under Item 7.01 (Regulation FD Disclosure) titled "Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption." While the actual press release content is not provided in the extracted text, the title suggests material business developments regarding platform adoption and commercial traction. This does not fit neatly into earnings_release (no financial results mentioned), ma_activity, or other specific event types, making other_material the most appropriate classification.
View raw filing on EDGAR →